Published in J Biomed Opt on March 09, 2010
Intravital microscopy as a tool to study drug delivery in preclinical studies. Adv Drug Deliv Rev (2010) 1.17
Two-photon and second harmonic microscopy in clinical and translational cancer research. Ann Biomed Eng (2012) 1.01
Digital correction of motion artefacts in microscopy image sequences collected from living animals using rigid and nonrigid registration. J Microsc (2011) 0.83
Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors. Am J Cancer Res (2011) 0.83
PhagoSight: an open-source MATLAB® package for the analysis of fluorescent neutrophil and macrophage migration in a zebrafish model. PLoS One (2013) 0.76
The Use of Second Harmonic Generation to Image the Extracellular Matrix During Tumor Progression. Intravital (2015) 0.75
High-speed focal modulation microscopy using acousto-optical modulators. Biomed Opt Express (2010) 0.75
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol (2003) 2.35
Rapid actin transport during cell protrusion. Science (2003) 2.11
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol (2007) 1.76
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J Clin Invest (2011) 1.66
Quantitative assessment of skin layers absorption and skin reflectance spectra simulation in the visible and near-infrared spectral regions. Physiol Meas (2002) 1.63
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Res (2002) 1.47
Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. EMBO J (2002) 1.36
Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. EMBO J (2003) 1.29
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies. Int J Exp Pathol (2009) 1.25
Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI. NMR Biomed (2002) 1.16
From bench to bedside for gene-directed enzyme prodrug therapy of cancer. Anticancer Drugs (2005) 1.12
The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol (2002) 1.08
Three-dimensional optic axis determination using variable-incidence-angle polarization-optical coherence tomography. Opt Lett (2006) 1.03
Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale. PLoS One (2012) 1.02
Tumour targeting by microtubule-depolymerizing vascular disrupting agents. Expert Opin Ther Targets (2007) 1.01
Oxygen regulation of tumor perfusion by S-nitrosohemoglobin reveals a pressor activity of nitric oxide. Circ Res (2005) 1.00
Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther (2002) 0.99
Evidence for protein 4.1B acting as a metastasis suppressor. J Cell Sci (2007) 0.94
Drift-Diffusion Analysis of Neutrophil Migration during Inflammation Resolution in a Zebrafish Model. Adv Hematol (2012) 0.93
Phytotoxicity and bioavailability of cobalt to plants in a range of soils. Chemosphere (2009) 0.93
Is mean blood saturation a useful marker of tissue oxygenation? Am J Physiol Heart Circ Physiol (2009) 0.92
Repelled from the wound, or randomly dispersed? Reverse migration behaviour of neutrophils characterized by dynamic modelling. J R Soc Interface (2012) 0.92
Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models. Int J Cancer (2002) 0.92
Neutrophil-delivered myeloperoxidase dampens the hydrogen peroxide burst after tissue wounding in zebrafish. Curr Biol (2012) 0.91
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo. Microcirculation (2008) 0.91
Experimental validation of an extended Jones matrix calculus model to study the 3D structural orientation of the collagen fibers in articular cartilage using polarization-sensitive optical coherence tomography. Biomed Opt Express (2012) 0.90
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proc Natl Acad Sci U S A (2010) 0.90
Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy. Clin Cancer Res (2002) 0.87
Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression. BMC Cancer (2006) 0.86
EKV mutant connexin 31 associated cell death is mediated by ER stress. Hum Mol Genet (2009) 0.86
Absolute fast axis determination using non-polarization-maintaining fiber-based polarization-sensitive optical coherence tomography. Opt Lett (2012) 0.86
Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapy. J Cell Biochem (2002) 0.84
Comparative study of the angle-resolved backscattering properties of collagen fibers in bovine tendon and cartilage. J Biomed Opt (2011) 0.84
Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeability. Int J Radiat Oncol Biol Phys (2007) 0.83
Polypyrrole nanoparticles: a potential optical coherence tomography contrast agent for cancer imaging. Adv Mater (2011) 0.83
Using swept-source optical coherence tomography to monitor the formation of neo-epidermis in tissue-engineered skin. J Tissue Eng Regen Med (2010) 0.82
CAIMAN: an online algorithm repository for Cancer Image Analysis. Comput Methods Programs Biomed (2010) 0.81
Optic axis determination by fibre-based polarization-sensitive swept-source optical coherence tomography. Phys Med Biol (2011) 0.81
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down. Int J Oncol (2007) 0.81
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate. Int J Cancer (2011) 0.81
Recombinant " IMS TAG" proteins--a new method for validating bottom-up matrix-assisted laser desorption/ionisation ion mobility separation mass spectrometry imaging. Rapid Commun Mass Spectrom (2013) 0.80
The aging eyewitness: effects of age on face, delay, and source-memory ability. J Gerontol B Psychol Sci Soc Sci (2003) 0.80
Effects of tin-protoporphyrin IX on blood flow in a rat tumor model. Exp Biol Med (Maywood) (2003) 0.80
Enhancement of vascular targeting by inhibitors of nitric oxide synthase. Int J Radiat Oncol Biol Phys (2002) 0.79
Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro. J Biomed Opt (2011) 0.79
Online chromatic and scale-space microvessel-tracing analysis for transmitted light optical images. Microvasc Res (2012) 0.79
Anti-biofouling conducting polymer nanoparticles as a label-free optical contrast agent for high resolution subsurface biomedical imaging. Biomaterials (2013) 0.78
A Robust and Artifact Resistant Algorithm of Ultrawideband Imaging System for Breast Cancer Detection. IEEE Trans Biomed Eng (2015) 0.78
Measuring red blood cell flow dynamics in a glass capillary using Doppler optical coherence tomography and Doppler amplitude optical coherence tomography. J Biomed Opt (2004) 0.78
Hospital door handle design and their contamination with bacteria: a real life observational study. Are we pulling against closed doors? PLoS One (2012) 0.78
Method to calibrate phase fluctuation in polarization-sensitive swept-source optical coherence tomography. J Biomed Opt (2011) 0.78
Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4. J Med Chem (2016) 0.78
Analysis of the horseradish peroxidase/indole-3-acetic acid combination in a three-dimensional tumor model. Cancer Gene Ther (2004) 0.77
The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro. Anticancer Res (2003) 0.77
Fluorescence localization after photobleaching (FLAP). Curr Protoc Cell Biol (2004) 0.77
Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins. J Transl Med (2012) 0.77
Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies. Int J Cancer (2013) 0.77
Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents. Med Eng Phys (2010) 0.77
MALDI-MSI and label-free LC-ESI-MS/MS shotgun proteomics to investigate protein induction in a murine fibrosarcoma model following treatment with a vascular disrupting agent. Proteomics (2014) 0.76
Targeting cancer with gene therapy using hypoxia as a stimulus. Methods Mol Med (2004) 0.76
The use of podcasts to enhance research-teaching linkages in undergraduate nursing students. Nurse Educ Pract (2012) 0.76
PhagoSight: an open-source MATLAB® package for the analysis of fluorescent neutrophil and macrophage migration in a zebrafish model. PLoS One (2013) 0.76
Performance comparison between 8- and 14-bit-depth imaging in polarization-sensitive swept-source optical coherence tomography. Biomed Opt Express (2011) 0.75
Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling. Biosci Rep (2012) 0.75
Generation of a novel mouse model for the inducible depletion of macrophages in vivo. Genesis (2012) 0.75
Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy - spatial and time dependent distribution. BMC Cancer (2004) 0.75
The clinical use of plasma clozapine levels in a maximum security setting. Int J Psychiatry Clin Pract (2008) 0.75
Fix the system to find the finances. Health Serv J (2011) 0.75
Polarization-sensitive optical coherence tomography using continuous polarization modulation with arbitrary phase modulation amplitude. J Biomed Opt (2012) 0.75